These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


487 related items for PubMed ID: 27792289

  • 21. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 22. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED, Souza PS, Lieberknecht V, Fidelis GS, Barbosa RI, Silveira PC, de Pinho RA, Dutra RC.
    Autoimmunity; 2016 Nov; 49(2):132-42. PubMed ID: 26703077
    [Abstract] [Full Text] [Related]

  • 23. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ, Ha D, Hwang I, Park E, Ahn G, Song JY, Jee Y.
    Am J Chin Med; 2016 Nov; 44(6):1099-1110. PubMed ID: 27627913
    [Abstract] [Full Text] [Related]

  • 24. Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
    Navarrete C, García-Martin A, Garrido-Rodríguez M, Mestre L, Feliú A, Guaza C, Calzado MA, Muñoz E.
    Neurobiol Dis; 2020 Sep; 143():104994. PubMed ID: 32599064
    [Abstract] [Full Text] [Related]

  • 25. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.
    Proc Natl Acad Sci U S A; 2007 May 01; 104(18):7558-63. PubMed ID: 17463082
    [Abstract] [Full Text] [Related]

  • 26. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
    Höflich KM, Beyer C, Clarner T, Schmitz C, Nyamoya S, Kipp M, Hochstrasser T.
    Brain Res; 2016 Nov 01; 1650():125-133. PubMed ID: 27592741
    [Abstract] [Full Text] [Related]

  • 27. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ, Figgitt DP.
    CNS Drugs; 2004 Nov 01; 18(6):379-96. PubMed ID: 15089110
    [Abstract] [Full Text] [Related]

  • 28. Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.
    Cahill LS, Zhang MA, Ramaglia V, Whetstone H, Sabbagh MP, Yi TJ, Woo L, Przybycien TS, Moshkova M, Zhao FL, Rojas OL, Gomes J, Kuerten S, Gommerman JL, Sled JG, Dunn SE.
    Proc Natl Acad Sci U S A; 2019 Nov 05; 116(45):22710-22720. PubMed ID: 31641069
    [Abstract] [Full Text] [Related]

  • 29. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA, Waldner H, Zagon IS, McLaughlin PJ.
    Exp Biol Med (Maywood); 2016 Jan 05; 241(1):71-8. PubMed ID: 26202376
    [Abstract] [Full Text] [Related]

  • 30. An overall view of the most common experimental models for multiple sclerosis.
    Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, Frau J, Cocco E, Fadda P.
    Neurobiol Dis; 2023 Aug 05; 184():106230. PubMed ID: 37453561
    [Abstract] [Full Text] [Related]

  • 31. Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease.
    Thompson KK, Nissen JC, Pretory A, Tsirka SE.
    Front Immunol; 2018 Aug 05; 9():2784. PubMed ID: 30555470
    [Abstract] [Full Text] [Related]

  • 32. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 05; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 33. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
    Leva G, Klein C, Benyounes J, Hallé F, Bihel F, Collongues N, De Seze J, Mensah-Nyagan AG, Patte-Mensah C.
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec 05; 1863(12):3016-3027. PubMed ID: 28899788
    [Abstract] [Full Text] [Related]

  • 34. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 05; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 35. Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis.
    Buonvicino D, Ranieri G, Guasti D, Pistolesi A, La Rocca AI, Rapizzi E, Chiarugi A.
    Neurobiol Dis; 2023 Mar 05; 178():106015. PubMed ID: 36702320
    [Abstract] [Full Text] [Related]

  • 36. Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models.
    Moles L, Egimendia A, Osorio-Querejeta I, Iparraguirre L, Alberro A, Suárez J, Sepúlveda L, Castillo-Triviño T, Muñoz-Culla M, Ramos-Cabrer P, Otaegui D.
    ACS Chem Neurosci; 2021 Mar 03; 12(5):893-905. PubMed ID: 33566588
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
    Stanojlovic M, Pang X, Lin Y, Stone S, Cvetanovic M, Lin W.
    PLoS One; 2016 Mar 03; 11(7):e0160158. PubMed ID: 27466819
    [Abstract] [Full Text] [Related]

  • 38. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P, Schmitz C, Bartenstein P, Rominger A, Kipp M.
    Cells; 2019 Jan 28; 8(2):. PubMed ID: 30696113
    [Abstract] [Full Text] [Related]

  • 39. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
    Melero-Jerez C, Alonso-Gómez A, Moñivas E, Lebrón-Galán R, Machín-Díaz I, de Castro F, Clemente D.
    Neurobiol Dis; 2020 Jul 28; 140():104869. PubMed ID: 32278882
    [Abstract] [Full Text] [Related]

  • 40. Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis.
    Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I.
    J Neurosci Res; 2018 Jun 28; 96(6):1021-1042. PubMed ID: 29446144
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.